Search Results 371-380 of 17598 for tsh

  1. A Study To Evaluate The Effect Of Olorinab On Gastrointestinal Transit In Patients With Irritable Bowel Syndrome - Mayo Clinic

    The purpose of this study is to evaluate gastric, small-bowel, and colonic transit in subjects with IBS-C and IBS-D treated with multiple (three times daily) ...

  2. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  3. Hematology - Clinical trials

    Hematology — Learn about innovative diagnosis and treatment options for blood diseases, including cancers, at Mayo Clinic.

  4. Neurology - Clinical trials - Mayo Clinic

    Aims, purpose, or objectives: To describe the clinical features along with treatment outcomes of a cohort of patients with a diagnosis of NMOSD after the ...

  5. Neurology - Clinical trials - Mayo Clinic

    The purpose of this study is to understand how electrical stimulation of the brain can modulate and suppress interictal epileptiform activity as a step on ...

  6. Mayo Clinic

    Rectal Cancer Surgery Outcomes Enhanced with Colorectal Surgeons David Etzioni · There's still time! · About Mayo Clinic · Medical Professionals · Businesses.

  7. Mayo Clinic

    YouTube-Saint Marys Campus Patient Guide Mayo Clinic Hospital - Rochester Minnesota · There's still time! · About Mayo Clinic · Medical Professionals · Businesses.

  8. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  9. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  10. A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment - Mayo Clinic

    The objective of Study M15-991 is to evaluate the efficacy and safety of risankizumab versus placebo during induction therapy in subjects with moderately to ...